AI assistant
Sending…
Replimune Group, Inc. — Director's Dealing 2023
Sep 21, 2023
33193_dirs_2023-09-20_df8991cf-ed4c-43c0-8e25-22498a02181b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2023-09-18
Reporting Person: Hill Emily Luisa (Chief Financial Officer)
More from Replimune Group, Inc.
Director's Dealing
2026
Feb 20
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Regulatory Filings
2026
Jan 12
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19